BRIEF published on 10/14/2024 at 22:35, 1 year 6 months ago DBV Technologies Share Capital Status as of September 30, 2024 Share Capital Voting Rights DBV Technologies Euronext Exchanges Listed Shares
BRIEF published on 09/23/2024 at 22:35, 1 year 6 months ago DBV Technologies Completes Screening of Subjects for Phase 3 VITESSE Clinical Trial Clinical Trial Phase 3 DBV Technologies Viaskin Peanut Peanut Allergy
PRESS RELEASE published on 09/23/2024 at 22:30, 1 year 6 months ago DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial DBV Technologies completes screening for VITESSE Phase 3 Clinical Trial evaluating Viaskin Peanut Patch in peanut allergic children ages 4-7. Topline results expected Q4 2025 Clinical Trial DBV Technologies Food Allergies VITESSE Phase 3 Viaskin Peanut Patch
BRIEF published on 09/04/2024 at 22:35, 1 year 7 months ago DBV Technologies to Participate in 26th Annual HC Wainwright Global Investment Conference DBV Technologies Viaskin Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy
PRESS RELEASE published on 09/04/2024 at 22:30, 1 year 7 months ago DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
BRIEF published on 08/02/2024 at 22:35, 1 year 8 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 8 months ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
BRIEF published on 07/30/2024 at 23:35, 1 year 8 months ago DBV Technologies makes its 2024 Half-Year Financial Report available AMF Financial Report DBV Technologies Food Allergy Viaskin™
PRESS RELEASE published on 07/30/2024 at 23:30, 1 year 8 months ago DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2024 Half-Year Report with AMF and offers access via website or request. Company develops treatments for food allergies using Viaskin platform AMF DBV Technologies Food Allergies 2024 Half-Year Report Viaskin Platform
BRIEF published on 07/30/2024 at 22:35, 1 year 8 months ago DBV Technologies: Progress for Viaskin Peanut and financial results for the first half of 2024 Financial Results Research And Development DBV Technologies Food Allergy Viaskin Peanut
Published on 04/23/2026 at 14:00, 3 minutes ago Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 13:00, 1 hour 3 minutes ago NOA Lithium Announces Mobilization of 2026 Exploration Drilling Program At Rio Grande Project
Published on 04/23/2026 at 13:00, 1 hour 3 minutes ago Sun Peak Metals Samples Up To 6.73 G/T Gold From The Newly Identified Hilux Zone At The Al Miyah Project
Published on 04/23/2026 at 13:00, 1 hour 3 minutes ago Ur-Energy Commences Operations at its Shirley Basin ISR Project, Wyoming, Advancing U.S. Uranium Production
Published on 04/23/2026 at 13:43, 20 minutes ago clearvise optimizes portfolio by capitalizing on favorable market conditions: Successful sale of small-scale PV division
Published on 04/23/2026 at 13:02, 1 hour 1 minute ago EQS-Adhoc: fox e-mobility AG: insolvency of the Swiss subsidiary revoked
Published on 04/23/2026 at 13:00, 1 hour 3 minutes ago CHAPTERS Group Invites Investors to Capital Markets Day
Published on 04/23/2026 at 08:00, 6 hours 3 minutes ago Mersen Signs A Contract with Vulcan Energy as part of Europe’s Battery industry initiative
Published on 04/23/2026 at 07:00, 7 hours 3 minutes ago bioMérieux – First-Quarter 2026 Business Review
Published on 04/23/2026 at 07:00, 7 hours 3 minutes ago Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond
Published on 04/22/2026 at 17:45, 20 hours 18 minutes ago Air Liquide to invest over 350M USD to support steel industry and strengthen its footprint in Louisiana
